Washington, D.C. – The Board of Pharmacy Specialties (BPS) is pleased to announce the new Specialty Council members for the Cardiology, Geriatric and Infectious Diseases Pharmacy Specialties. The appointments for Cardiology and Infectious Diseases will begin immediately and the Geriatrics appointments will begin January 1, 2018.

A BPS Specialty Council serves the following purposes:

  • To recommend to the Board of Pharmacy Specialties standards and other requirements for certification and recertification of pharmacists in the specialty.
  • To develop and administer examinations as required for certification and recertification of pharmacists in the specialty.
  • To evaluate the qualifications of individual pharmacists and to submit to the Board of Pharmacy Specialties the names of those pharmacists recommended for certification or recertification in the specialty.

A Specialty Council is composed of nine (9) members.  Seven (7) members of each Specialty Council are pharmacists holding BPS Board Certification in that pharmacy specialty. Two (2) members of each Specialty Council are pharmacists who do not hold Board certification in the council’s specialty area. Since Cardiology and Infectious Diseases are new specialties, the first Council will replace original appointees with individuals who earn board certification in these specialties over a three year period beginning after the first examination is offered in Fall 2018. The Geriatric Pharmacy Specialty Council will establish a staggered rotation to assure continuity while creating opportunities for new leadership.

BPS Executive Director William Ellis commented, “The Board of Pharmacy Specialties received close to 100  responses to the call for Council volunteers for 27 positions. We are very fortunate to have nationally recognized subject matter experts and pharmacy leaders as part of the board certification process. The professionalism and expertise of the Council members enable each specialty to maintain a high standard of quality in their work to recognize the advanced knowledge of pharmacists who are BPS Board Certified.”

Cardiology Pharmacy

The Cardiology pharmacy petition was submitted jointly by the American College of Clinical Pharmacy, American Pharmacists Association and the American Society of Health-System Pharmacists and approved by BPS in February  2017.

The petitioning organizations have defined Cardiology Pharmacy practice as follows:

Cardiology Pharmacy practice specializes in the delivery of direct patient care services by pharmacists as members of interprofessional healthcare teams, working to ensure the safe and effective use of medications in patients with cardiovascular disease. These specialists focus on disease prevention and treatment, including evidence-based medication use and related care that improve both short- and long-term outcomes for patients. Cardiology specialists practice across the spectrum of care, including ambulatory, acute and intensive care. Pharmacists in this practice review, analyze and monitor multifaceted clinical information to make reasoned decisions for patients with multiple comorbidities and highly complex mediation regimens.

 

Council Member Appointments:

Kristen B. Campbell, BCPS-AQ Cardiology
Duke University Hospital
Durham, NC

Robert J. DiDomenico, PharmD, BCPS-AQ Cardiology, FCCP, FHFSA
University of Illinois at Chicago
Chicago, IL

Dina Hunsinger-Norris, PharmD, BCPS-AQ Cardiology
Lebanon VA Medical Center
Lebanon, PA

John P. Lindsley, PharmD, BCPS-AQ Cardiology
The Johns Hopkins Hospital
Baltimore, MD

Tien M. H. Ng, PharmD, BCPS-AQ Cardiology
University of Southern California, School of Pharmacy
Los Angeles, CA

Joseph J. Saseen, PharmD, BCPS, BCACP
University of Colorado Anschutz Medical Campus School of Pharmacy
Aurora, CO

Anne M. Schullo-Feulner, PharmD, BCPS
University of Minnesota, College of Pharmacy
Minneapolis, MN

Sarah A. Spinler, PharmD, BCPS-AQ Cardiology
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia
Philadelphia, PA

Sheila L. Stadler, PharmD, BCPS-AQ Cardiology
Kaiser Permanente-Colorado
Denver, CO

 

Geriatric Pharmacy

In the Fall of 2016, the Board of the Commission for Certification in Geriatric Pharmacy (CCGP)

voted to move the Certified Geriatric Pharmacist credential under the portfolio of certifications offered by the Board

of Pharmacy Specialties. At the end of December 2016, CCGP assets were dissolved and consolidated with the Board of Pharmacy Specialties. During 2017, the geriatric credential is still in the process of transition but it will be fully integrated into the Board of Pharmacy Specialties by January 1, 2018.

 

Geriatric Pharmacy can be defined as:

Geriatric Pharmacy Practice specializes in applying the knowledge of pharmacodynamics and pharmacokinetics of medications in older adults to optimize therapeutic outcomes.  Pharmacists in geriatric practice apply the pharmacist patient care process to provide person-centered care to older adults with complex medication regimens and multiple comorbidities. The practice includes direct patient care; collaboration with interprofessional health care teams; education of patients, caregivers, and other health care professionals; and advocacy for appropriate medication use in these individuals.  Geriatric Pharmacy Practice uniquely improves public health by identifying, preventing, and resolving medication-related problems in older adults, while promoting optimal therapeutic and humanistic outcomes.

 

Council Member Appointments:

Tara Bruneski, BPharm, BCGP, BCPS
Peter Lougheed Centre Inpatient Pharmacy
Alberta Health Services
Calgary, Alberta, Canada

Crystal D. Burkhardt, PharmD, MBA, BCPS, BCGP
University of Kansas
Kansas City, Kansas

Stephanie M. (Seaton) Crist, PharmD, BCACP, BCGP
Barnes-Jewish Hospital Primary Care Medicine Clinic
St. Louis, Missouri

Stefan R. Kowalski, BPharm, MAppSci, BCGP
University of South Australia, School of Pharmacy and Medical Sciences
Adelaide, South Australia

Sunny A. Linnebur, PharmD, BCPS, BCGP
University of Colorado Skaggs, School of Pharmacy
Aurora, Colorado

Jessica W. Merrey, PharmD, MBA, BCPS, BCACP, BCGP
The Johns Hopkins Hospital
Baltimore, Maryland

Terrence E. O’Shea, PharmD, BCGP
Omnicare (A CVS Health Company)
Englewood, Ohio

Non-Specialist Members

Lawrence J. Cohen, PharmD, BCPP
University of North Texas System College of Pharmacy
Fort Worth, Texas

Carol J. Rollins, MS, PharmD, BCNSP
University Medical Center
Tucson, Arizona

 

Infectious Diseases Pharmacy

The Infectious diseases pharmacy petition was submitted jointly by the American College of Clinical Pharmacy, American Pharmacists Association, American Society of Health-System Pharmacists and the Society of Infectious Diseases Pharmacists.  The specialty was approved in February 2017.

The petitioning organizations have defined Infectious Diseases Pharmacy practice as follows:

Infectious Diseases Pharmacy practice specializes in the use of microbiology and pharmacology to develop, implement, and monitor drug regimens that incorporate the pharmacodynamics and pharmacokinetics of antimicrobials to optimize therapy for patients. The practice requires pharmacists to use clinical and evidence-driven knowledge to develop appropriate antimicrobial therapies to more rapidly resolve infections while decreasing adverse events, complications and resistance. The practice includes direct patient care provided through interprofessional health care teams, collaborative leadership of antimicrobial stewardship programs, education of health care providers, preventive services including immunizations, and advocacy for appropriate antimicrobial utilization. Specialty pharmacy practice in infectious diseases uniquely improves public health by optimizing antimicrobial potential in individual patients and narrowing the resistance trends that occur in society by preventing progression of antimicrobial resistance and infectious diseases.

 

Infectious Diseases Pharmacy Specialty Council Member Appointments:

Edina Avdic, PharmD, MBA, BCPS-AQID
The Johns Hopkins Hospital
Baltimore, MD

Russell Benefield, PharmD, BCPS-AQ ID
University of Utah College of Pharmacy
Salt Lake City, UT

Whitney Buckel, PharmD, BCPS-AQ ID
Intermountain Healthcare
Salt Lake City, UT

Kathryn Dzintars, PharmD, BCPS-AQ ID
The Johns Hopkins Hospital
Baltimore, MD

Douglas Fish, PharmD, BCPS-AQ ID
University of Colorado Anschutz Medical Campus School of Pharmacy
Aurora, CO

Jason Gallagher, PharmD, BCPS
Temple University School of Pharmacy
Philadelphia, PA

Elizabeth Leung, PharmD, MSCI, BCPS-AQ ID
Saint Michaels Hospital/University of Toronto
Toronto, Ontario, Canada

Brian Potoski, PharmD, BCPS-AQ ID
University of Pittsburgh Medical Center, Presbyterian Hospital
Pittsburgh, PA

Dennis Williams, PharmD, BCPS
UNC Eshelman School of Pharmacy
Chapel Hill NC

About the Board of Pharmacy Specialties

The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA).  The mission of the Board of Pharmacy Specialties is to improve patient care and increase awareness of the need for BPS Board Certified Pharmacists as integral members of multidisciplinary healthcare teams through recognition and promotion of specialized training, knowledge, and skills in pharmacy and specialty board certification and recertification of pharmacists throughout the world. Through the rigorous standards mandated by BPS board certification and recertification, the BPS board certified pharmacist stands out as the most qualified to accept today’s expanding professional expectations.  Today over 30,000 pharmacists hold BPS certification.

 

###